|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
|
SE9604581D0
(sv)
*
|
1996-12-12 |
1996-12-12 |
Karolinska Innovations Ab |
An agent against cancer and virus infections
|
|
US6251665B1
(en)
|
1997-02-07 |
2001-06-26 |
Cem Cezayirli |
Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
|
|
US6228640B1
(en)
|
1997-02-07 |
2001-05-08 |
Cem Cezayirli |
Programmable antigen presenting cell of CD34 lineage
|
|
US6977073B1
(en)
|
1997-02-07 |
2005-12-20 |
Cem Cezayirli |
Method for stimulating an immune response
|
|
US6133308A
(en)
*
|
1997-08-15 |
2000-10-17 |
Millennium Pharmaceuticals, Inc. |
Synthesis of clasto-lactacystin beta-lactone and analogs thereof
|
|
CN1271342A
(zh)
*
|
1997-08-15 |
2000-10-25 |
F·索西 |
裂－乳胱氨酸－β－内脂及其类似物的合成
|
|
MXPA00007893A
(es)
*
|
1998-02-11 |
2002-10-23 |
Maxygen Inc |
Direccion de vectores de vacunas geneticas.
|
|
US7390619B1
(en)
|
1998-02-11 |
2008-06-24 |
Maxygen, Inc. |
Optimization of immunomodulatory properties of genetic vaccines
|
|
EP1518927A3
(en)
*
|
1998-02-11 |
2005-06-22 |
Maxygen, Inc. |
Optimization of immunomodulatory properties of genetic vaccines
|
|
JP2002506622A
(ja)
*
|
1998-03-20 |
2002-03-05 |
ジェンザイム・コーポレーション |
抗原提示細胞上での亢進した抗原提示の方法、およびそれにより産生する組成物
|
|
US6436392B1
(en)
*
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
GB9817693D0
(en)
*
|
1998-08-14 |
1998-10-07 |
Bridgehead Technologies Limite |
Virally-mediated targeting of drugs and genetic material
|
|
CN1339970A
(zh)
*
|
1999-02-10 |
2002-03-13 |
鹤尾隆 |
抗癌药物增强剂
|
|
US7122335B1
(en)
*
|
1999-06-08 |
2006-10-17 |
University Of Iowa Research Foundation |
Compounds and methods to enhance rAAV transduction
|
|
JP4969002B2
(ja)
*
|
1999-06-08 |
2012-07-04 |
ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン |
ｒＡＡＶ形質導入を増加するための化合物および方法
|
|
AT408721B
(de)
*
|
1999-10-01 |
2002-02-25 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung enthaltend ein antigen
|
|
US7241447B1
(en)
|
1999-10-07 |
2007-07-10 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors and uses thereof
|
|
US6649593B1
(en)
*
|
1999-10-13 |
2003-11-18 |
Tularik Inc. |
Modulators of SREBP processing
|
|
JP2007524379A
(ja)
*
|
2003-03-31 |
2007-08-30 |
ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン |
上皮ナトリウムチャンネル関連障害のＰｈａｒｍｉｃｏ−遺伝子治療
|
|
US20060167106A1
(en)
*
|
2004-11-19 |
2006-07-27 |
Mei Zhang |
Compounds acting at the centrosome
|
|
CA2649325C
(en)
|
2006-04-14 |
2019-01-08 |
Epicentre Technologies Corporation |
Kits and methods for generating 5' capped rna
|
|
AU2007243184A1
(en)
*
|
2006-04-28 |
2007-11-08 |
University Of Iowa Research Foundation |
Methods and compounds to modulate parvovirus transduction of mammalian cells or to alter virus infection, method to identify a viral receptor or co-receptor
|
|
ES2526548T3
(es)
|
2006-08-18 |
2015-01-13 |
Argos Therapeutics, Inc. |
Uso de CD83 en terapias de combinación
|
|
EP2557089A2
(en)
|
2011-07-15 |
2013-02-13 |
Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Compositions and methods for immunomodulation
|
|
WO2017139381A1
(en)
|
2016-02-08 |
2017-08-17 |
University Of Iowa Research Foundation |
Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
|
|
CA3198936A1
(en)
|
2016-03-07 |
2017-09-14 |
University Of Iowa Research Foundation |
Aav-mediated expression using a synthetic promoter and enhancer
|
|
US12173305B2
(en)
|
2016-05-26 |
2024-12-24 |
University Of Iowa Research Foundation |
cis and trans requirements for terminal resolution of human bocavirus 1
|
|
US11142775B2
(en)
|
2017-01-13 |
2021-10-12 |
University Of Iowa Research Foundation |
Bocaparvovirus small noncoding RNA and uses thereof
|